1. Home
  2. FIEE vs TXMD Comparison

FIEE vs TXMD Comparison

Compare FIEE & TXMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FiEE Inc

FIEE

FiEE Inc

HOLD

Current Price

$6.74

Market Cap

23.0M

Sector

Utilities

ML Signal

HOLD

Logo TherapeuticsMD Inc.

TXMD

TherapeuticsMD Inc.

HOLD

Current Price

$2.35

Market Cap

25.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FIEE
TXMD
Founded
N/A
2008
Country
United States
United States
Employees
43
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
23.0M
25.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
FIEE
TXMD
Price
$6.74
$2.35
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
N/A
98.0K
Earning Date
N/A
03-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.03
Revenue
N/A
$2,796,000.00
Revenue This Year
N/A
$427.09
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$90.45
Revenue Growth
N/A
75.19
52 Week Low
N/A
$0.72
52 Week High
N/A
$2.95

Technical Indicators

Market Signals
Indicator
FIEE
TXMD
Relative Strength Index (RSI) 70.58 53.93
Support Level $4.20 $2.33
Resistance Level $5.65 $2.51
Average True Range (ATR) 1.00 0.21
MACD 0.11 -0.02
Stochastic Oscillator 75.47 58.70

Price Performance

Historical Comparison
FIEE
TXMD

About FIEE FiEE Inc

FiEE Inc, formerly Minim Inc is a digital service provider focused on integrating artificial intelligence and data analytics into content creation and brand management. The company offers a range of services designed to support creators, artists, and businesses in developing, managing, and optimizing their digital presence across various platforms, including customized graphic and posts, short videos, and editorial calendars aligned with brand goals.

About TXMD TherapeuticsMD Inc.

TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.

Share on Social Networks: